We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$3.75B
AUM Growth
+$262M
Cap. Flow
+$43.7M
Cap. Flow %
1.16%
Top 10 Hldgs %
12.53%
Holding
738
New
210
Increased
177
Reduced
155
Closed
194

Sector Composition

Rank Sector Weight
1 Technology 23.67%
2 Industrials 12.71%
3 Real Estate 10.58%
4 Consumer Discretionary 9.11%
5 Utilities 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVE icon
501
Wave Life Sciences
WVE
$1.12B
$382K 0.01%
+45,000
New +$493K
SOAC.U
502
DELISTED
Sustainable Opportunities Acquisition Corp. Units, each consisting of one Class A ordinary share and
SOAC.U
$379K 0.01%
34,306
-65,970
-66% -$697K
HRTX icon
503
Heron Therapeutics
HRTX
$93.4M
$374K 0.01%
25,216
-4,284
-15% -$66.8K
CNI icon
504
Canadian National Railway
CNI
$78.5B
$373K 0.01%
3,504
-11,496
-77% -$1.15M
TCMD icon
505
Tactile Systems Technology
TCMD
$618M
$369K 0.01%
10,087
+115
+1% +$4.21K
JBLU icon
506
JetBlue
JBLU
$2.16B
$365K 0.01%
+32,205
New +$361K
MDB icon
507
MongoDB
MDB
$25.8B
$348K 0.01%
1,503
-2,575
-63% -$558K
OPCH icon
508
Option Care Health
OPCH
$3.58B
$335K 0.01%
+25,048
New +$304K
SVACU
509
DELISTED
Starboard Value Acquisition Corp. Unit
SVACU
$328K 0.01%
+32,433
New +$328K
EPZM
510
DELISTED
Epizyme, Inc
EPZM
$326K 0.01%
27,304
+4,579
+20% +$61.3K
KPTI icon
511
Karyopharm Therapeutics
KPTI
$155M
$323K 0.01%
+1,476
New +$361K
HDS
512
DELISTED
HD Supply Holdings, Inc.
HDS
$316K 0.01%
+7,663
New +$293K
SAGE
513
DELISTED
Sage Therapeutics
SAGE
$308K 0.01%
5,042
+56
+1% +$2.84K
RLMD icon
514
Relmada Therapeutics
RLMD
$540M
$301K 0.01%
+8,000
New +$309K
CTLT
515
DELISTED
CATALENT, INC.
CTLT
$300K 0.01%
+3,508
New +$297K
AUPH icon
516
Aurinia Pharmaceuticals
AUPH
$1.95B
$297K 0.01%
+20,170
New +$292K
EWG icon
517
iShares MSCI Germany ETF
EWG
$1.56B
$271K 0.01%
9,315
-251,832
-96% -$7.38M
ICAD
518
DELISTED
iCAD Inc
ICAD
$265K 0.01%
30,039
+8,181
+37% +$80.8K
GNMK
519
DELISTED
GenMark Diagnostics, Inc
GNMK
$256K 0.01%
18,000
-2,000
-10% -$30.6K
LLY icon
520
Eli Lilly
LLY
$1.08T
$252K 0.01%
+1,700
New +$263K
MRUS
521
DELISTED
Merus
MRUS
$251K 0.01%
20,956
+235
+1% +$3.04K
AAL icon
522
American Airlines Group
AAL
$9.82B
$246K 0.01%
+20,039
New +$251K
TXMD icon
523
TherapeuticsMD
TXMD
$23.8M
$246K 0.01%
3,120
+34
+1% +$2.71K
ML
524
DELISTED
MoneyLion Inc.
ML
$246K 0.01%
+833
New +$245K
SDC
525
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$234K 0.01%
20,000
-430,009
-96% -$3.95M

Similar funds

Weiss Multi-Strategy Advisers's Q3 2020 Portfolio in Review

As of Q3 2020, Weiss Multi-Strategy Advisers held 738 positions worth $3.75B, up 7.5% from $3.49B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Weiss Multi-Strategy Advisers's Q3 2020 filing shows 210 new, 177 increased, 155 reduced and 194 closed positions. Its largest new stake was Mondelez International: 732,375 shares worth $42.1M. The largest sale was Norfolk Southern, an estimated $55.4M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 18% a quarter earlier, followed by Industrials and Real Estate.

  • Weiss Multi-Strategy Advisers's largest Q3 2020 buy was Mondelez International: 732,375 shares worth $42.1M.
  • Weiss Multi-Strategy Advisers added most to Palo Alto Networks in Q3 2020, an estimated $38.9M increase.
  • Weiss Multi-Strategy Advisers's biggest Q3 2020 reduction was Norfolk Southern, cutting an estimated $55.4M.
  • Weiss Multi-Strategy Advisers fully exited Innovative Industrial Properties in Q3 2020, selling an estimated $30.2M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 13% of its $3.75B portfolio in Q3 2020.
  • Weiss Multi-Strategy Advisers opened 210 new positions and closed 194 in Q3 2020.
  • Weiss Multi-Strategy Advisers's portfolio value rose 7.5% quarter-over-quarter to $3.75B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2020, filed 16 Nov 2020.